Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |